Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefano Bonora

Showing results (191-200 of 302) with videos related to

Pageof 31
Sort By:
Frontiers in Microbiology|April 18, 2022
Determinants of SARS-CoV-2 Contagiousness in Household Contacts of Symptomatic Adult Index CasesMattia Trunfio, Lorenzo Richiardi, Francesca Alladio, et al.
Antiviral Therapy|January 28, 2021
Early low-molecular-weight heparin administration is associated with shorter time to SARS-CoV-2 swab negativityMattia Trunfio, Elena Salvador, Alberto Gaviraghi, et al.
AIDS (London, England)|July 24, 2020
Dual antiretroviral therapies are effective and safe regimens in the central nervous system of neurologically symptomatic people living with HIVMattia Trunfio, Walter Rugge, Lorenzo Mighetto, et al.
BMC Psychiatry|August 27, 2024
Developing a validated methodology for identifying clozapine treatment periods in electronic health recordsAviv Segev, Risha Govind, Ebenezer Oloyede, et al.
Hepatology (Baltimore, Md.)|September 8, 2011
Ribavirin pharmacokinetics and interleukin 28B plus cytochrome P450 27B1 single-nucleotide polymorphisms as predictors of response to pegylated interferon/ribavirin treatment in patients infected with hepatitis C virus genotype 1/4Antonio D'Avolio, Alessia Ciancio, Marco Siccardi, et al.
International Journal of Antimicrobial Agents|March 20, 2024
Host single nucleotide polymorphisms and biomarkers of neuronal damage and inflammation in people living with HIVJessica Cusato, Alessandra Manca, Alice Palermiti, et al.
AIDS (London, England)|December 5, 2015
Tenofovir clearance is reduced in HIV-positive patients with subclinical tubular impairmentAndrea Calcagno, Jessica Cusato, Letizia Marinaro, et al.
The Journal of Antimicrobial Chemotherapy|May 20, 2008
Pharmacokinetic and pharmacodynamic determinants of early virological response to enfuvirtide-based regimens in HIV-positive patientsDaniel Gonzalez de Requena, Stefano Bonora, Antonella Castagna, et al.
The Journal of Antimicrobial Chemotherapy|September 30, 2017
Atazanavir intracellular concentrations remain stable during pregnancy in HIV-infected patientsEmanuele Focà, Andrea Calcagno, Andrea Bonito, et al.
Antimicrobial Agents and Chemotherapy|May 16, 2018
Pharmacokinetic Changes during Pregnancy According to Genetic Variants: a Prospective Study in HIV-Infected Patients Receiving Atazanavir-RitonavirEmanuele Focà, Andrea Calcagno, Andrea Bonito, et al.
Pageof 31

Showing results (191-200 of 302) with videos related to

Sort By:
Pageof 31
Frontiers in Microbiology|April 18, 2022
Determinants of SARS-CoV-2 Contagiousness in Household Contacts of Symptomatic Adult Index CasesMattia Trunfio, Lorenzo Richiardi, Francesca Alladio, et al.
Antiviral Therapy|January 28, 2021
Early low-molecular-weight heparin administration is associated with shorter time to SARS-CoV-2 swab negativityMattia Trunfio, Elena Salvador, Alberto Gaviraghi, et al.
AIDS (London, England)|July 24, 2020
Dual antiretroviral therapies are effective and safe regimens in the central nervous system of neurologically symptomatic people living with HIVMattia Trunfio, Walter Rugge, Lorenzo Mighetto, et al.
BMC Psychiatry|August 27, 2024
Developing a validated methodology for identifying clozapine treatment periods in electronic health recordsAviv Segev, Risha Govind, Ebenezer Oloyede, et al.
Hepatology (Baltimore, Md.)|September 8, 2011
Ribavirin pharmacokinetics and interleukin 28B plus cytochrome P450 27B1 single-nucleotide polymorphisms as predictors of response to pegylated interferon/ribavirin treatment in patients infected with hepatitis C virus genotype 1/4Antonio D'Avolio, Alessia Ciancio, Marco Siccardi, et al.
International Journal of Antimicrobial Agents|March 20, 2024
Host single nucleotide polymorphisms and biomarkers of neuronal damage and inflammation in people living with HIVJessica Cusato, Alessandra Manca, Alice Palermiti, et al.
AIDS (London, England)|December 5, 2015
Tenofovir clearance is reduced in HIV-positive patients with subclinical tubular impairmentAndrea Calcagno, Jessica Cusato, Letizia Marinaro, et al.
The Journal of Antimicrobial Chemotherapy|May 20, 2008
Pharmacokinetic and pharmacodynamic determinants of early virological response to enfuvirtide-based regimens in HIV-positive patientsDaniel Gonzalez de Requena, Stefano Bonora, Antonella Castagna, et al.
The Journal of Antimicrobial Chemotherapy|September 30, 2017
Atazanavir intracellular concentrations remain stable during pregnancy in HIV-infected patientsEmanuele Focà, Andrea Calcagno, Andrea Bonito, et al.
Antimicrobial Agents and Chemotherapy|May 16, 2018
Pharmacokinetic Changes during Pregnancy According to Genetic Variants: a Prospective Study in HIV-Infected Patients Receiving Atazanavir-RitonavirEmanuele Focà, Andrea Calcagno, Andrea Bonito, et al.
Pageof 31